X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

SkyCell partners with All Nippon Airways to support Japanese pharma market

Content Team by Content Team
13th September 2021
in News, Packaging & Logistic
SkyCell partners with All Nippon Airways to support Japanese pharma market

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

At SkyCell, we have expanded our airline partnerships into Japan by partnering with All Nippon Airways (ANA), the country’s largest airline. This collaboration will not only strengthen our support for pharmaceutical customers shipping in and out of Japan, but will also benefit ANA in reaching their own sustainability goals.

Our partnership with ANA will include all the temperature ranges that we have, from -80°C to -60°C, -30°C to -15°C, +2°C to +8°C and +15°C to + 25°C. This gives their customers access to all cold chain internal temperature conditions to facilitate safe, secure and sustainable shipments. With Japan being a pivotal segment in the pharma market, our collaboration with ANA, as well as the utilization of our hybrid container solutions into their cold chain, will ensure the timely arrival of life-saving medicines in the region.

ANA and their customers will see why hybrid containers are an ideal solution to issues faced in modern pharma supply chains. Our hybrid containers can maintain stable temperatures without the need for external charging for long periods of time, meaning special infrastructure is not needed to keep the containers at optimal temperatures. By using lightweight, environmentally-friendly material, the technology enables efficiency and reusability. Additionally, they are shock-absorbent and can mitigate any breakage during transport, whilst a double-door system protects the packaging in high-humidity countries.

Furthermore, working towards a sustainable supply chain is also a fundamental part of our partnership. ANA, like many airlines, also has its own sustainability targets and seeks to collaborate with those who have a similar outlook. At SkyCell, sustainability is part of our DNA. We have joined the SBTi, launched our own sustainability report and committed to the Paris Agreement. By partnering with SkyCell, ANA has a collaborator that shares their sustainable vision, and will utilize containers that cut CO2 by half and don’t contribute to landfill waste.

Finally, SkyCell currently has one service center in Japan. This will also support the Japanese market with container availability and bring SkyCell’s hybrid to this essential segment of the pharma industry.

Previous Post

CEVEC and UCB sign agreement for the use of CEVECS ELEVECTA AAV manufacturing technology in Gene Therapy

Next Post

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

IBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In